Australasian Recurrent Pregnancy Loss Clinical Management Guideline 2024 Part I

Adriana Suker, Ying Li, Danielle Robson, Anthony Marren, the Australasian CREI (Certificate of Reproductive Endocrinology and Infertility) Consensus Expert Panel on Trial Evidence (ACCEPT) group, Neil Johnson, Neerja Kamal

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)
103 Downloads (Pure)

Abstract

Guidelines for the investigation and management of recurrent pregnancy loss (RPL) have been developed in Europe, USA and UK, but there is currently no Australasian guideline. The Australasian Certificate of Reproductive Endocrinology and Infertility Consensus Expert Panel on Trial Evidence group has prepared a two-part guideline to provide guidance on the management of RPL. In Part I chromosomal, anatomical, and endocrine factors are outlined along with relevant recommendations for clinical management, levels of evidence and grades of consensus. In Part II thrombophilia, autoimmune factors, infective, inflammatory, and endometrial causes, environmental and lifestyle factors, male factor and unexplained causes will be outlined.

Original languageEnglish
Pages (from-to)432-444
Number of pages13
JournalAustralian and New Zealand Journal of Obstetrics and Gynaecology
Volume64
Issue number5
DOIs
Publication statusPublished - Oct 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • guideline
  • recurrent miscarriage
  • recurrent pregnancy loss
  • RPL

Fingerprint

Dive into the research topics of 'Australasian Recurrent Pregnancy Loss Clinical Management Guideline 2024 Part I'. Together they form a unique fingerprint.

Cite this